BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
234 hedge funds and large institutions have $4.39B invested in Blueprint Medicines in 2020 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 88 increasing their positions, 67 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10% more funds holding
Funds holding: 213 → 234 (+21)
1.46% more ownership
Funds ownership: 102.35% → 103.81% (+1.5%)
21% less call options, than puts
Call options by funds: $43.6M | Put options by funds: $55.5M
Holders
234
Holding in Top 10
7
Calls
$43.6M
Puts
$55.5M
Top Buyers
| 1 | +$59.9M | |
| 2 | +$41.1M | |
| 3 | +$24.6M | |
| 4 |
First Manhattan
New York
|
+$24.2M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$24.1M |
Top Sellers
| 1 | -$105M | |
| 2 | -$59.6M | |
| 3 | -$41.9M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$32.2M |
| 5 |
Alkeon Capital Management
New York
|
-$31.2M |